Key genes of various fatty acid oxidation reactions are regulated by PPARα expression [13], and targeting PPARα to regulate its expression and transcriptional activity has become a new strategy for the treatment of NAFLD [22]. This evidence concerns the gene PPARA and metabolic dysfunction-associated steatotic liver disease.